Simponi (SIM-po-nee), a new tumor necrosis factor (TNF) blocker for rheumatoid arthritis

Reps will be promoting Simponi (SIM-po-nee), a new tumor necrosis factor (TNF) blocker for rheumatoid arthritis.

It's an alternative to Enbrel, Humira, or Remicade for rheumatoid and other forms of inflammatory arthritis.

There's no proof that any TNF blocker is more effective than another for improving symptoms and slowing progression.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote